Skip to main content
. 2020 Mar 4;9:9. doi: 10.1186/s40035-020-00187-1

Table 2.

Rating scale assessments

Rating scale
UPDRS Part I (mentation, behavior and mood); mean ± SD
 Baseline (n = 477) 2.3 ± 2.1
 3 months (n = 393) 1.9 ± 1.9
 Change from baseline (n = 393) − 0.3 ± 1.5
UPDRS Part II (ADL during OFF); mean ± SD
 Baseline (n = 476) 17.1 ± 7.0
 3 months (n = 391) 13.9 ± 6.8
 Change from baseline (n = 391) − 3.0 ± 4.6
P value vs. baseline < 0.0001
UPDRS Part III (motor scores during ON); mean ± SD
 Baseline (n = 477) 26.5 ± 12.1
 3 months (n = 393) 21.5 ± 11.0
 Change from baseline (n = 393) − 4.6 ± 8.1
P value vs. baseline < 0.0001
UPDRS Total scores (Part II + III); mean ± SD
 Baseline (n = 477) 37.5 ± 16.9
 3 months (n = 393) 30.5 ± 15.2
 Change from baseline (n = 393) − 6.4 ± 10.4
P value vs. baseline < 0.0001
UPDRS Part IV (complications of therapy); mean ± SD
 Baseline (n = 475) 5.2 ± 2.6
 3 months (n = 391) 4.2 ± 2.4
 Change from baseline (n = 391) − 0.8 ± 1.9
PDQ-8 Total Score; mean ± SD
 Baseline (n = 476) 29.2 ± 16.4
 3 months (n = 393) 25.2 ± 15.8
 Change from baseline (n = 393) − 3.4 ± 12.8
P value vs. baseline < 0.0001
NMSS Score; mean ± SD
 Baseline (n = 477) 44.6 ± 30.3
 3 months (n = 393) 37.0 ± 26.7
 Change from baseline (n = 393) − 6.8 ± 19.7
P value vs. baseline < 0.0001

NMSS Non-motor symptom scale, UPDRS Unified Parkinson’s Disease Rating Scale, PDQ-8 Parkinson’s Disease Questionnaire